The FDA has issued a safety alert regarding Baxter’s Novum IQ large-volume infusion pumps, following reports of serious adverse events, including two patient deaths. The agency highlights growing concerns about potential underinfusion linked to the devices.
This update follows an earlier warning about the same issue, which initially cited one serious injury and no fatalities. As of June 27, Baxter has reported 79 serious injuries and two deaths associated with the malfunction.
The Novum IQ pumps, designed for precise fluid delivery in clinical settings, may not consistently deliver intended volumes, posing significant risks to patients. The FDA has urged healthcare providers to remain vigilant and follow updated usage guidelines as it continues investigating the matter.
Follow MEDWIRE.AI for critical FDA updates and medtech safety news.
